Bank of New York Mellon’s Humacyte HUMA Stock Holding History

Bank of New York Mellon’s Portfolio HUMA Stock Details HUMA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$43.6K	Sell	55,844 -297,566	-84%	-$276K	﹤0.01%	4246
2026 Q1	$214K	Buy	353,410 +9,659	+3%	+$10K	﹤0.01%	3979
2025 Q4	$330K	Buy	343,751 +21,395	+7%	+$30.3K	﹤0.01%	3815
2025 Q3	$561K	Buy	322,356 +23,758	+8%	+$46.5K	﹤0.01%	3522
2025 Q2	$624K	Buy	298,598 +109,201	+58%	+$210K	﹤0.01%	3387
2025 Q1	$323K	Sell	189,397 -2,983	-2%	-$11.2K	﹤0.01%	3667
2024 Q4	$972K	Sell	192,380 -1,834	-0.9%	-$9.07K	﹤0.01%	3182
2024 Q3	$1.06M	Sell	194,214 -59,799	-24%	-$394K	﹤0.01%	3110
2024 Q2	$1.22M	Buy	254,013 +97,931	+63%	+$510K	﹤0.01%	3079
2024 Q1	$485K	Sell	156,082 -20,270	-11%	-$68.2K	﹤0.01%	3539
2023 Q4	$501K	Sell	176,352 -88,056	-33%	-$226K	﹤0.01%	3548
2023 Q3	$775K	Buy	264,408 +3,302	+1%	+$10.9K	﹤0.01%	3318
2023 Q2	$747K	Sell	261,106 -1,069	-0.4%	-$3.85K	﹤0.01%	3380
2023 Q1	$810K	Sell	262,175 -5,532	-2%	-$15.7K	﹤0.01%	3229
2022 Q4	$565K	Buy	267,707 +197,931	+284%	+$601K	﹤0.01%	3482
2022 Q3	$227K	Buy	69,776 +13,536	+24%	+$51.9K	﹤0.01%	3963
2022 Q2	$180K	Buy	56,240 +29,598	+111%	+$165K	﹤0.01%	4095
2022 Q1	$188K	Buy	+26,642	New	+$155K	﹤0.01%	4266

Other funds holding HUMA

Antipodes Partners Royal Exchange, Australia $5.46B AUM 26.64% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

GCP

GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return

PAG

Private Advisor Group Morristown, New Jersey $21.8B AUM 28.57% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wealth Effects Boston, Massachusetts $370M AUM 97.79% 1-Year Est. Return

IEQ Capital Foster City, California $21.7B AUM 77.3% 1-Year Est. Return

LWM

LJI Wealth Management Indianapolis, Indiana $714M AUM 21.51% 1-Year Est. Return

UAS

United Asset Strategies Garden City, New York $1.41B AUM 27.73% 1-Year Est. Return

Bank of New York Mellon's HUMA Position: Q2 2026 in Review

Bank of New York Mellon reduced its Humacyte (HUMA) stake by 84% in Q2 2026, selling an estimated $276K and leaving 55,844 shares worth $43.6K. The position accounts for ﹤0.01% of the portfolio, ranked #4246.

Bank of New York Mellon first reported a position in HUMA in Q1 2022 and has held it in 18 quarters since. The position peaked at $1.22M in Q2 2024. 83 funds tracked by Wall St. Rank hold HUMA as of Q2 2026.

Bank of New York Mellon held 55,844 shares of Humacyte worth $43.6K as of Q2 2026.
Bank of New York Mellon sold 297,566 Humacyte shares in Q2 2026, an estimated $276K.
Humacyte made up ﹤0.01% of Bank of New York Mellon's portfolio in Q2 2026, its #4246 holding.
Bank of New York Mellon first reported a position in Humacyte in Q1 2022 and has held it in 18 quarters since.
Bank of New York Mellon's Humacyte position peaked at $1.22M in Q2 2024.
83 funds tracked by Wall St. Rank held Humacyte as of Q2 2026.

Based on Bank of New York Mellon's 13F filing for Q2 2026, filed 6 Aug 2026.